IAVI at World Vaccine Congress Europe 2026
Oct 19–21, 2026 Amsterdam, Netherlands ~2k attendees Website
IAVI takes part in 6 sessions at World Vaccine Congress Europe 2026 in Amsterdam. Its program centres on vaccine platforms built on recombinant vesicular stomatitis virus (rVSV), including their use to develop a Bundibugyo virus vaccine. Other sessions weigh whether tuberculosis vaccines can deliver on their promise and which antimicrobial resistance targets to prioritise.
| Organization | World Vaccine Congress Europe 2026 Attendance |
|---|---|
IAVI New York, NY | |
Non-profit research organization developing vaccines and antibodies for HIV, tuberculosis and emerging infectious diseases. | Talk Mon Oct 19 11:30 Talk Mon Oct 19 11:45 Panel Mon Oct 19 12:15 Talk Wed Oct 21 10:30 Panel Wed Oct 21 13:15 Panel: Rethinking AMR Priorities: Choosing the Targets That Move the Needle How to choose which drug-resistant bacteria to target with vaccines and antibody drugs, using cost-effectiveness models to line up funders and drugmakers. Panel Wed Oct 21 14:30 Panel: Can TB vaccines deliver on the promise? What tuberculosis vaccine trials can learn from COVID-19, flu and respiratory syncytial virus, and how to make tuberculosis a funding priority. |
Instantly find 20 buyers from IAVI
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Terrapinn or the World Vaccine Congress. Submit a correction